The aim — to improve the diagnosis and surgical treatment results of renal cell carcinoma, complicated with thrombosis of the inferior vena cava and right atrium.Materials and methods. The results of clinical examination, laboratory indicators, instrumental, intraoperative observations and morphological studies were analysed in 76 patients with renal cell carcinoma, complicated with thrombosis of the inferior vena cava and right atrium, who were hospitalized to the Vascular Surgery department for the period from 1993 to 2017 years.Results and discussion. Surgical treatment included radical nephrectomy in combination with thrombectomy from the inferior vena cava and right atrium. The average operation duration was 220 min, the median blood loss was 900 ml (500 — 3000 ml). Intraoperative autogemotransfusion with the «CellSaver Plus» method allowed to reduce significantly the blood loss and the donor blood need. The intraoperative mortality rate was 2.6 %. The postoperative complications included: pulmonary embolism — in 5 (6.6 %), acute renal failure — in 6 (7.9 %), liver failure — in 5 (6.6 %), posthemorrhagic anemia — in 23 (30.2 %), phlebothrombosis — in 2 (2.6 %), suppuration of the postoperative wound — in 3 (3.9 %) cases. The causes of postoperative lethality included: pulmonary embolism — in 1 (1.3 %), hemorrhagic shock — in 1 (1.3 %), pulmonary insufficiency — in 1 (1.3 %) case. The followup period was from 1 to 22 years. Twoyear survival was confirmed in 77.1 %.Conclusions. The choice of optimal tactics for surgical intervention in patients with renal cell carcinoma, complicated with thrombosis of the inferior vena cava and right atrium, is determined by the different levels of venous invasion, which, in the context of a multidisciplinary approach, will minimize the risk of intra and postoperative complications, and improve longterm treatment outcomes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.